Efficacy and Safety of Cetuximab/Irinotecan in Chemotherapy-Refractory Metastatic Colorectal Adenocarcinomas: A Clinical Practice Setting, Multicenter Experience-Reference-Cited by-同舟云学术

Efficacy and Safety of Cetuximab/Irinotecan in Chemotherapy-Refractory Metastatic Colorectal Adenocarcinomas: A Clinical Practice Setting, Multicenter Experience

Published:2006-03 Issue:6 Volume:5 Page:422-428
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Gebbia Vittorio,Del Prete Salvatore,Borsellino Nicoló,Ferraú Francesco,Tralongo Paolo,Verderame Francesco,Leonardi Vita,Capasso Elena,Maiello Evaristo,Bordonaro Roberto,Stinco Sergio,Agostara Biagio,Barone Carlo

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference32 articles.

1. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends;Howe;J Nat Cancer Inst,2001

2. Chemotherapy for colorectal cancer;Moertel;N Engl J Med,1994

3. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group;Saltz;N Engl J Med,2000

4. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial;Douillard;Lancet,2000

5. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer;Giacchetti;J Clin Oncol,2000

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy re-use versus anti-angiogenic monotherapy as the third-line treatment of patients with metastatic colorectal cancer: a real-world cohort study;BMC Cancer;2024-03-05

2. Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer;BMC Cancer;2024-01-02

3. Efficacy and safety of third-line or later-line targeted treatment for patients with metastatic colorectal cancer: a meta-analysis;Frontiers in Oncology;2023-05-31

4. Cetuximab-Induced Aseptic Meningitis in a Patient with Colorectal Cancer: A Case Report and Review of Literature;Case Reports in Neurology;2022-11-28

5. Patient demographics and management landscape of metastatic colorectal cancer in the third‐line setting: Real‐world data in an australian population;Asia-Pacific Journal of Clinical Oncology;2021-04-18